Valve selection

[Lynlw]

Direct quote of the second key point (which they put in bold) from the first report:

"With the innovative new drugs [Pradaxa, bivalirudin, argatroban, Xarelto, apixaban] on the horizon, it now appears unlikely that mechanical heart valve patients will be maintained with warfarin for more than a few years."

A few years, seriously? Marketing is one thing, blatantly misleading information is quite another. Shame on On-X.

I started to respond to the ON-X cherry picking for marketting, but alot had been said before.
but one of the things on the article you are referring to, is first it is about Coumadin for people who HAD MI's and STROKES compared to aspirin alone NOT valve patients and even then the best they could say is
"Based on these results, belief that warfarin is especially dangerous in elderly valve patients may perhaps be exaggerated."